Drug discovery, rethought.
AzeoRx was founded on a simple premise: the tools of modern drug discovery have changed, but the way most discovery companies use them has not. Most labs still work one paper, one hypothesis, one target at a time — and miss the patterns that only emerge when the full scientific landscape is evaluated systematically.
We built a proprietary platform that operates continuously across the breadth of biomedical knowledge. It surfaces high-value therapeutic opportunities that conventional approaches miss, and our scientific leadership directs which findings advance to chemistry.
The approach is already producing results. AzeoRx holds a portfolio of filed provisional patent applications on novel therapies spanning neuromuscular, oncology, cardiovascular, and autoimmune disease areas. We are a focused scientific operation anchored in a proprietary research engine, a disciplined methodology, a growing intellectual property portfolio, and deep scientific leadership.
